The Use of Biologics and the Effects of Co-Morbidities in Psoriasis
Speakers: John Koo, MD & Nicholas Brownstone, MD
1 CME Credit
John Koo, MD
Dr. Koo graduated from Harvard Medical School. He is board certified in both Psychiatry and Dermatology. He finished his dermatology residency at University of California San Francisco Medical Center and Psychiatry residency at UCLA Neuropsychiatric Institute. He has been a faculty at University of California San Francisco Medical Center Department of Dermatology. He has more than 300 peer reviewed publications. He is the chief editor for a two volume textbook on psoriasis where “mild to moderate psoriasis” volume is now in its third edition and “moderate to severe psoriasis” is in its fourth edition. This two volume textbooks is one of the most widely used in USA. Dr. Koo was named “best researcher in dermatology” at SID meeting. He also received the “best speaker” award at Fall Clinical Conference. He received the best mentor award from UCSF. Lastly, he was honored for “lifetime achievement award” by National Psoriasis Foundation.
Nicholas Brownstone, MD
Dr. Brownstone received a BA degree in Psychology from Cornell University and attended medical school at Rutgers Robert Wood Johnson. He is currently a clinical research fellow at the UCSF Psoriasis and Skin Treatment Center in the Department of Dermatology.
Clinical Research Fellow
Psoriasis and Skin Treatment Center
Department of Dermatology
University of California, San Francisco
What to expect:
- Discuss the prevalence of co-morbidities in the psoriatic population
- Review the currently commercially available biologic therapies and how they may impact psoriasis co-morbidities
- Understand how psoriasis can affect rates of depression and how appropriate therapy can increase a patient’s quality of life
- Review recommendations for monitoring a patient on biologic therapy with co-morbidities
Submit your question(s) for the presenter here: